SEARCH

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policies, and Terms of Service.

    Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India

    7 hours ago

    Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a semaglutide injection 2.4 mg for weight loss, the statement said.
    Click here to Read more
    Prev Article
    National Education Day: Celebrating Maulana Abul Kalam Azads Vision For An Educated India
    Next Article
    India Highlights Efforts On Evidence-Based Traditional Medicine Ahead Global Summit

    Related Breaking News Updates:

    Comments (0)

      Leave a Comment